Publications by authors named "Ching-Chi Liu"

Claim this Profile
T
Titers and breadth of neutralizing antibodies against SARS-CoV-2 variants after heterologous booster vaccination in health care workers primed with two doses of ChAdOx1 nCov-19: A single-blinded, randomized clinical trial.
Chih-Hsien Chuang, Chung-Guei Huang, Ching-Tai Huang, Yi-Ching Chen, Yu-An Kung, Ching-Chi Liu

J Clin Virol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dexamethasone Intravitreal Implant as Adjunctive Therapy to Ranibizumab in Neovascular Age-Related Macular Degeneration: A Multicenter Randomized Controlled Trial.
Baruch D Kuppermann, Michaella Goldstein, Raj K Maturi, Ayala Pollack, Michael Singer, Ching-Chi Liu

Ophthalmologica· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dexamethasone intravitreal implant in combination with laser photocoagulation for the treatment of diffuse diabetic macular edema.
David G Callanan, Sunil Gupta, David S Boyer, Thomas A Ciulla, Michael A Singer, Ching-Chi Liu

Ophthalmology· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, controlled comparison of macroscopic conjunctival hyperemia in patients treated with bimatoprost 0.01% or vehicle who were previously controlled on latanoprost.
E Randy Craven, Ching-Chi Liu, Amy Batoosingh, Rhett M Schiffman, Scott M Whitcup

Clin Ophthalmol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The safety and efficacy of bimatoprost/timolol fixed combination: a 1-year double-masked, randomized parallel comparison to its individual components in patients with glaucoma or ocular hypertension.
Richard A Lewis, Ronald L Gross, Kenneth N Sall, Rhett M Schiffman, Ching Chi Liu

J Glaucoma· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of brimonidine purite 0.1% and brimonidine purite 0.15%: a meta-analysis of two phase 3 studies.
Louis B Cantor, Ching-Chi Liu, Amy L Batoosingh, David A Hollander

Curr Med Res Opin· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brimonidine-purite 0.1% versus brimonidine-purite 0.15% twice daily in glaucoma or ocular hypertension: a 12-month randomized trial.
Louis B Cantor, Eleonora Safyan, Ching-Chi Liu, Amy L Batoosingh

Curr Med Res Opin· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis